Form 4: Outset Medical CEO Sells Shares for Tax Obligations
Insider Transaction Report
Outset Medical's Chair and CEO, Leslie Trigg, sold 3,361 shares of common stock to cover tax withholding obligations related to RSU vesting.
Summary
- Leslie Trigg, Chair and CEO of Outset Medical, Inc. (OM), reported a transaction involving the sale of common stock.
- A total of 3,361 shares of common stock were disposed of at a price of $3.35 per share.
- The sale was a 'sell to cover' transaction, specifically to satisfy partial tax withholding obligations associated with the vesting of 9,319 Restricted Stock Units (RSUs).
- These RSUs were granted to Leslie Trigg on January 12, 2024, and June 10, 2025.
- The transaction does not represent a discretionary trade by the reporting person.
- Following the reported transaction, Leslie Trigg directly beneficially owns 102,342 shares of common stock.
- Indirect beneficial ownership includes 41,666 shares through the Trigg 2002 Rev Trust and 584 shares through the Trigg Family Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was non-discretionary and solely for tax withholding purposes related to RSU vesting, a standard practice in executive compensation.
Positives
- The vesting of 9,319 Restricted Stock Units (RSUs) represents a positive compensation event for the Chair and CEO, Leslie Trigg.
Negatives
- A reduction in direct beneficial ownership of 3,361 shares of common stock by the Chair and CEO, Leslie Trigg.
Future Outlook
na
Management Comments
- The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.
Industry Context
StockSavvy.ai notes that 'sell to cover' transactions are a common mechanism for executives to manage tax liabilities arising from equity compensation, and this filing reflects a routine compensation event rather than a strategic divestment. Such transactions are standard practice across various industries when Restricted Stock Units (RSUs) vest.
Stakeholder Impact
- Minor impact on shareholders due to a small, non-discretionary sale of common stock by the CEO.
- Positive impact on the reporting person (Leslie Trigg) through the vesting of RSUs and subsequent tax obligation management.
Key Dates
| Date | Description |
|---|---|
| 01/12/2024 | Grant date for a portion of the Restricted Stock Units (RSUs) that vested. |
| 06/10/2025 | Grant date for a portion of the Restricted Stock Units (RSUs) that vested. |
| 02/17/2026 | Date of the reported transaction (sale of common stock). |
| 02/19/2026 | Date the Form 4 was signed. |
Recommendation
holdThis Form 4 reports a routine 'sell to cover' transaction by the CEO to satisfy tax obligations from RSU vesting. It is not a discretionary sale and therefore does not signal a change in management's confidence or the company's outlook, warranting a neutral 'hold' recommendation based solely on this filing.
Keywords
Outset Medical, OM, Leslie Trigg, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Tax Withholding, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.